NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ:
Post# of 174
(Total Views: 205)
Posted On: 03/30/2020 3:13:03 PM
NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces 2019 Annual Results
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced annual results for the year ended December 31, 2019. According to the update, the company reported $7.43 million in revenues from continuing operations compared to $3.83 million for 2018, as well as $125,244 in operating income for the year 2019 compared to an operating loss of ($87,616) in 2018. “In addition to increased revenue growth from our companies, Trxade Group achieved a number of significant milestones around innovation and enhancements in 2019 that add even more value to our role as a strategic provider to independent pharmacies and lower cost healthcare to all consumers,” Trxade Group Chairman and CEO Suren Ajjarapu said in the news release. “We believe our platform will become even more important for our customers in the years to come. We have a clear vision of our strategy and the opportunities ahead and look forward to another successful year of growth.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced annual results for the year ended December 31, 2019. According to the update, the company reported $7.43 million in revenues from continuing operations compared to $3.83 million for 2018, as well as $125,244 in operating income for the year 2019 compared to an operating loss of ($87,616) in 2018. “In addition to increased revenue growth from our companies, Trxade Group achieved a number of significant milestones around innovation and enhancements in 2019 that add even more value to our role as a strategic provider to independent pharmacies and lower cost healthcare to all consumers,” Trxade Group Chairman and CEO Suren Ajjarapu said in the news release. “We believe our platform will become even more important for our customers in the years to come. We have a clear vision of our strategy and the opportunities ahead and look forward to another successful year of growth.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scienture Holdings, Inc. (SCNX) Stock Research Links
Scroll down for more posts ▼